Repro Med Systems Stock Investor Sentiment

KRMD Stock  USD 3.98  0.06  1.49%   
About 56% of all Repro Med's shareholders are looking to take a long position. The analysis of overall sentiment of trading Repro Med Systems stock suggests that some investors are interested at this time. The current market sentiment, together with Repro Med's historical and current headlines, can help investors time the market. In addition, many technical investors use Repro Med Systems stock news signals to limit their universe of possible portfolio assets.
  

Repro Med Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Repro Med can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
over a year ago at thelincolnianonline.com         
KORU Medical Systems, Inc. Director Purchases 49,590.00 in Stock
news
over a year ago at news.google.com         
HCSC charts 3rd straight year of MA expansion for 2024 - FierceHealthcare
Google News at Macroaxis
over a year ago at news.google.com         
IceCure Medical Reports First Half 2023 Financial Operational Results Global Adoption of Cryoablatio...
Google News at Macroaxis
over a year ago at insidermonkey.com         
KORU Medical Systems, Inc. Q2 2023 Earnings Call Transcript
insidermonkey News
over a year ago at news.google.com         
Are thyroid disorders to be blamed for early menopause - Health shots
Google News at Macroaxis
over a year ago at finance.yahoo.com         
Companies Like KORU Medical Systems Are In A Position To Invest In Growth
Yahoo News
over a year ago at businesswire.com         
KORU Medical Systems, Inc. Announces 2023 Second Quarter Financial Results and Updates Full Year 202...
businesswire News
over a year ago at zacks.com         
Masimo Q2 Earnings Miss Estimates
zacks News
over a year ago at news.google.com         
NuVasive reports mixed Q2 results ahead of expected merger with ... - Mass Device
Google News at Macroaxis
over a year ago at seekingalpha.com         
KORU Medical Systems expects Q2 revenue growth at 6
seekingalpha News
over a year ago at zacks.com         
Penumbra Surpasses Q2 Earnings and Revenue Estimates
zacks News
over a year ago at businesswire.com         
KORU Medical Systems to Report Second Quarter Financial Results on August 9, 2023
businesswire News
over a year ago at thelincolnianonline.com         
KORU Medical Systems versus Innovative Eyewear Financial Comparison
news
over a year ago at news.google.com         
Abortion in America How access and attitudes have changed through the centuries - KSNT News
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Repro Med that are available to investors today. That information is available publicly through Repro media outlets and privately through word of mouth or via Repro internal channels. However, regardless of the origin, that massive amount of Repro data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Repro Med news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Repro Med relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Repro Med's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Repro Med alpha.

Repro Med Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Acquisition by Linda Tharby of 19681 shares of Repro Med at 2.09 subject to Rule 16b-3
09/20/2024
2
Acquisition by Manko Joseph M. Jr. of 5454 shares of Repro Med subject to Rule 16b-3
09/30/2024
3
Acquisition by Cascella Robert of 5454 shares of Repro Med at 2.75 subject to Rule 16b-3
10/01/2024
4
Further weakness as KORU Medical Systems drops 10 percent this week, taking five-year losses to 38
10/09/2024
5
LivaNova Tops Q3 Earnings and Revenue Estimates
10/30/2024
6
KORU Medical Systems Presents Data at Partnership Opportunities in Drug Delivery Conference Demonstrating Nursing Preference for Use of KORU FreedomEdge Infusio...
10/31/2024
7
Disposition of 721781 shares by Manko Joseph M. Jr. of Repro Med subject to Rule 16b-3
11/08/2024
8
KORU Medical Systems, Inc. Announces 2024 Q3 Financial Results, Third Consecutive Quarter of Double-Digit Growth Raises Full Year 2024 Guidance
11/13/2024
9
Koru Medical Systems stock target increased, holds buy on strong quarter
11/14/2024
10
KORU Medical Systems, Inc. Q3 2024 Earnings Call Transcript
11/15/2024
11
KRMD stock touches 52-week high at 3.41 amid robust growth - Investing.com Australia
11/21/2024
12
KORU Medical Systems to Participate in Piper Sandlers 36th Annual Healthcare Conference
11/25/2024

Complementary Tools for Repro Stock analysis

When running Repro Med's price analysis, check to measure Repro Med's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Repro Med is operating at the current time. Most of Repro Med's value examination focuses on studying past and present price action to predict the probability of Repro Med's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Repro Med's price. Additionally, you may evaluate how the addition of Repro Med to your portfolios can decrease your overall portfolio volatility.
Commodity Directory
Find actively traded commodities issued by global exchanges
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Money Managers
Screen money managers from public funds and ETFs managed around the world
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Fundamental Analysis
View fundamental data based on most recent published financial statements
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets